Drug recall D-0087-2024
Product
Buprenorphine HCl, Injection, 0.3mg/mL, For Intramuscular or Intravenous Use, Rx Only, 1mL Single Dose Vial, (supplied in packages of 5 vials) Distributed by Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC: 42023-179-05
Reason for recall
Crystallization; identified as Buprenorphine free base
Lots and codes
Lot No: 343716, Exp. Date: 11/2021; Lot No: 350565, Exp. Date: 07/2022; Lot No: 26921, Exp. Date: 07/2022; Lot No: 36227, Exp. Date: 02/2023
Recall details
- Recalling firm
- PAR Sterile Products LLC, Rochester, MI
- Distribution
- Nationwide USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 9, 2021
- Terminated
- September 29, 2024
Related products
- Buprenorphine Hydrochloride – drug information
- NDC 42023-179 Buprenorphine Hydrochloride · Buprenorphine Hydrochloride .324 mg/mL · Par Health USA, LLC